ICD-10 Coding for Invasive Ductal Carcinoma(C50.0, C50.312, C50.312B)
Comprehensive guide to coding invasive ductal carcinoma using ICD-10, including documentation requirements, pitfalls, and FAQs.
Complete code families applicable to Invasive Ductal Carcinoma
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C50.911 | Malignant neoplasm of unspecified site of right female breast | Use when the specific quadrant of the right breast is not documented. |
|
| C50.312 | Malignant neoplasm of upper-outer quadrant of left female breast | Use when the tumor is located in the upper outer quadrant of the left breast. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutInvasive Ductal Carcinoma
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Invasive Ductal Carcinoma.
Omitting laterality in documentation
Impact
Clinical: May lead to incorrect treatment planning., Regulatory: Non-compliance with coding standards., Financial: Potential for denied claims due to unspecified coding.
Mitigation
Always document the side of the breast affected.
Coding in situ carcinoma when invasive is present
Impact
Reimbursement: Incorrect DRG assignment may affect payment., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate cancer registry data.
Mitigation
Always code the invasive component when both are present.
Unspecified site coding
Impact
Using unspecified site codes without proper documentation.
Mitigation
Ensure documentation includes specific site and laterality.